Luke McLaughlin: Haemophilia Care as a Matter of Global Health Equity
Luke McLaughlin, Founder of The Haemophilia Rights Project, shared World Federation of Hemophilia‘s post on LinkedIn, adding:
“The significance of this milestone should not be understated.
The advancement of medical treatments in Haemophilia can only be seen as revolutionary if they are equally distributed around the globe.
No human should be too expensive or inconvenient to treat. Cost should never be an excuse to disregard human rights.
I commend Armenia, World Federation of Hemophilia and the unilateral coalition of supporting states for highlighting treatment equity in Haemophilia at the highest international level.
Treatment should be a right for all people with Haemophilia and bleeding disorders.”
World Federation of Hemophilia (WFH) shared a post on LinkedIn:
“Today marks a historic milestone for the global Bleeding Disorders community.
The 79th World Health Assembly has adopted the resolution on ‘Global action to advance health equity for people with hemophilia and other bleeding disorders.’
This landmark adoption recognizes the urgent need to improve diagnosis, access to treatment, comprehensive care, and health equity for people living with bleeding disorders around the world.
It signals commitment by the WHO and Member States to advance these priorities.
Watch the address of Cesar Garrido, the WFH President, at the WHA79.
The World Federation of Hemophilia extends its sincere gratitude to Armenia for its leadership, as well as to all co-sponsoring Member States – in addition to all the partners, advocates, healthcare professionals, national member organizations, and community members whose collaboration helped make this possible, including over 100 organizations that joined the WFH’s Global Call for Health Equity for Bleeding Disorders.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!
-
Jul 13, 2026, 05:57Barbara Adams Krolak: Exciting Updates From the ISTH 2026 Regulatory Session